Osaic Holdings’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Osaic Holdings’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,039	Closed	-$94	–	7677
2024 Q1	$94	Sell	1,039 -200	-16%	-$19	﹤0.01%	7043
2023 Q4	$130	Hold	1,239	–	–	﹤0.01%	7090
2023 Q3	$279	Buy	1,239 +150	+14%	+$40	﹤0.01%	7098
2023 Q2	$286	Sell	1,089 -200	-16%	-$39	﹤0.01%	7147
2023 Q1	$232	Sell	1,289 -400	-24%	-$92	﹤0.01%	7246
2022 Q4	$0	Hold	1,689	–	–	﹤0.01%	7490
2022 Q3	$1K	Sell	1,689 -5	-0.3%	-$3	﹤0.01%	7120
2022 Q2	$1K	Buy	+1,694	New	+$1.07K	﹤0.01%	7195
2022 Q1	–	Sell	-1,809	Closed	-$4K	–	7585
2021 Q4	$4K	Hold	1,809	–	–	﹤0.01%	6807
2021 Q3	$6K	Buy	+1,809	New	+$6.44K	﹤0.01%	6479

Other funds holding DNA.WS

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

JRCM

Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Osaic Holdings's DNA.WS Position: Q2 2024 in Review

Osaic Holdings sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q2 2024, closing a stake of 1,039 shares — an estimated $94 sold.

Osaic Holdings first reported a position in DNA.WS in Q3 2021 and held it in 10 quarters. The position peaked at $6K in Q3 2021. 28 funds tracked by Wall St. Rank hold DNA.WS as of Q2 2024.

Osaic Holdings reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q2 2024 after selling out during the quarter.
Osaic Holdings sold 1,039 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q2 2024, an estimated $94.
Osaic Holdings first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 10 quarters.
Osaic Holdings's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $6K in Q3 2021.
28 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q2 2024.

Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.